Unilife to Present at the Rodman and Renshaw Global Investment Conference

  Unilife Medical Solutions Limited (ASX: UNI)
(PINKSHEETS: UNIFF) today announced that it is scheduled to present at the
2009 Rodman & Renshaw Annual Global Investment Conference to be held in New
York City between September 9-11, 2009.

The Rodman and Renshaw Healthcare Conference is an annual event attended by invited institutional investors, sophisticated investors and private equity firms specializing in the biotechnology and life sciences sector. The Unilife presentation, to be given by CEO Alan Shortall, marks the first time the Company will present at a major U.S. investment conference.

Unilife recently announced its intention to undertake a proposed redomiciliation of the Company from Australia to the U.S., and a proposed listing on NASDAQ.

The date, time and location of the Unilife presentation at the Conference are as follows:

    Date: Thursday, September 10, 2009

    Time: 4.30pm (U.S. Eastern Time)

    Venue: Henry Salon (5th Floor), New York Palace Hotel, New York City

Unilife will place a copy of the presentation onto its website at www.unilife.com on Thursday, September 10 (U.S. Eastern Time).

Conference attendees seeking to schedule a one-on-one meeting with Unilife management between September 9 and 11, 2009 are encouraged to contact Stuart Fine via phone (+ 1 908 469 1788) or email [e-mail].

About Unilife

Unilife Medical Solutions Ltd. is an ISO 13485 certified company that designs, develops and supplies innovative safety medical devices. Listed on the Australian Securities Exchange (ASX: UNI) since 2002, Unilife has FDA-registered manufacturing facilities in the U.S. State of Pennsylvania and a proprietary portfolio of clinical and prefilled safety syringes designed for use within healthcare and pharmaceutical markets.

Shareholder / Analyst Enquiries: Australia Jeff Carter Phone: + 61 2 8346 6500 United States Stuart Fine Phone: + 1 908 469 1788